发明名称 CELL THERAPY FORMULATION METHOD AND COMPOSITION
摘要 Ex-vivo prepared T-cells are harvested from cell culture conditions and formulated in medium suitable for infusion. The formulation is made by labeling the cells with one or more agents which have reactivity for T-cell surface moieties capable of delivery activation signals upon cross-linking and mixing the labeled cells with biodegradable nanospheres or microspheres coated with a material capable of cross-linking the agents attached to the T-cell surface moieties. Alternatively, the formulation may be made by mixing a population of T-cells with biodegradable nanospheres or microspheres coated with a first material and one or more second materials. The first material binds the second material and the second material has reactivity for surface moieties on the T-cells and the interaction of the second materials with the T-cells causes the activation of the T-cells. In either method, the mixture of T-cells and biodegradable spheres are suspended in a medium suitable for infusion, and the mixture is packaged in a container.
申请公布号 EP1749090(A4) 申请公布日期 2009.04.29
申请号 EP20050724065 申请日期 2005.03.01
申请人 IMMUNOVATIVE THERAPIES, LTD. 发明人 HAR-NOY, MICHAEL
分类号 A61K35/14;C12N5/0783 主分类号 A61K35/14
代理机构 代理人
主权项
地址